Favorable gradients with the mitroflow aortic valve prosthesis in everyday surgery

Thoracic and Cardiovascular Surgeon

Volumn 60, Issue 5, 2012, Pages 326-334

  Hartrumpf, Martin ^a   Kuehnel, Ralf ^a   Erb, Michael ^a   Loladze, Giorgi ^a   Mueller, Torsten ^a   Albes, Johannes ^a  

^a Heart Center Brandenburg   (Germany)

Author keywords

aortic valve and root; heart valve surgery; outcomes (include mortality morbidity)

Indexed keywords

ACUTE KIDNEY FAILURE; AGED; AORTA ROOT; AORTA VALVE PROSTHESIS; AORTA VALVE REPLACEMENT; AORTIC ROOT SURGERY; ARTICLE; ATRIOVENTRICULAR BLOCK; BODY HEIGHT; BODY MASS; BODY SURFACE; BODY WEIGHT; CARDIOVASCULAR MORTALITY; CORONARY ARTERY BYPASS GRAFT; ENDOCARDITIS; FEMALE; GASTROINTESTINAL SYMPTOM; HEART ATRIUM FIBRILLATION; HEART TAMPONADE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; PATIENT SAFETY; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROSTHETIC VALVE THROMBOSIS; REOPERATION; TRACHEOSTOMY;

AGED; AORTIC VALVE; AORTIC VALVE STENOSIS; FEMALE; FOLLOW-UP STUDIES; GERMANY; HEART VALVE PROSTHESIS; HUMANS; MALE; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84865860320     PISSN: 01716425     EISSN: 14391902     Source Type: Journal    
DOI: 10.1055/s-0031-1299570     Document Type: Article

References (20)

1. Funder JA, Frost MW, Ringgaard S., et al. In-vivo blood velocity and velocity gradient profiles downstream of stented and stentless aortic heart valves. J Heart Valve Dis: 2010; 19 3 292 303
2. Gonzalez-Juanatey JR, Garcia-Bengoechea JB, Garcia-Acuna JM., et al. The influence of the design on the medium to long-term hemodynamic behavior of 19 mm pericardial aortic valve prostheses. J Heart Valve Dis: 1996; 5 03 S317 S323 (Pubitemid 26393625)
3. Yankah CA, Pasic M, Musci M., et al. Aortic valve replacement with the Mitroflow pericardial bioprosthesis: durability results up to 21 years. J Thorac Cardiovasc Surg: 2008; 136 3 688 696
4. ISTHMUS Investigators. The Italian study on the Mitroflow postoperative results (ISTHMUS): a 20-year, multicentre evaluation of Mitroflow pericardial bioprosthesis. Eur J Cardiothorac Surg: 2011; 39 1 18 26, discussion 26
5. Conte J, Weissman N, Dearani JA., et al. A North American, prospective, multicenter assessment of the Mitroflow aortic pericardial prosthesis. Ann Thorac Surg: 2010; 90 1 144 152, e1-e3
6. Bleiziffer S, Eichinger WB, Hettich IM., et al. Hemodynamic characterization of the Sorin Mitroflow pericardial bioprosthesis at rest and exercise. J Heart Valve Dis: 2009; 18 1 95 100
7. Jamieson WR, Koerfer R, Yankah CA., et al. Mitroflow aortic pericardial bioprosthesisclinical performance. Eur J Cardiothorac Surg: 2009; 36 5 818 824
8. Alvarez JR, Sierra J, Vega M., et al. Early calcification of the aortic Mitroflow pericardial bioprosthesis in the elderly. Interact Cardiovasc Thorac Surg: 2009; 9 5 842 846
9. Lang RM, Bierig M, Devereux RB., et al. Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr: 2005; 18 12 1440 1463 (Pubitemid 41821197)
10. Pibarot P, Dumesnil JG. Hemodynamic and clinical impact of prosthesis-patient mismatch in the aortic valve position and its prevention. J Am Coll Cardiol: 2000; 36 4 1131 1141
11. Benhameid O, Jamieson WR, Castella M., et al. CarboMedics Mitroflow pericardial aortic bioprosthesis - performance in patients aged 60 years and older after 15 years. Thorac Cardiovasc Surg: 2008; 56 4 195 199 (Pubitemid 351860734)
12. Vasan RS, Larson MG, Levy D. Determinants of echocardiographic aortic root size. The Framingham Heart Study. Circulation: 1995; 91 3 734 740
13. García-Bengochea J, Sierra J, González-Juanatey JR., et al. Left ventricular mass regression after aortic valve replacement with the new Mitroflow 12A pericardial bioprosthesis. J Heart Valve Dis: 2006; 15 3 446 451, discussion 451-452
14. Jamieson WR, Forgie WR, Hayden RI., et al. Hemodynamic performance of mitroflow aortic pericardial bioprosthesis - optimizing management for the small aortic annulus. Thorac Cardiovasc Surg: 2010; 58 2 69 75
15. Kuehnel RU, Puchner R, Pohl A., et al. Characteristic resistance curves of aortic valve substitutes facilitate individualized decision for a particular type. Eur J Cardiothorac Surg: 2005; 27 3 450 455, discussion 455 (Pubitemid 40312353)
16. Stelfox HT, Ahmed SB, Ribeiro RA, Gettings EM, Pomerantsev E, Schmidt U. Hemodynamic monitoring in obese patients: the impact of body mass index on cardiac output and stroke volume. Crit Care Med: 2006; 34 4 1243 1246
17. de Simone G, Devereux RB, Daniels SR., et al. de SG. Stroke volume and cardiac output in normotensive children and adults. Assessment of relations with body size and impact of overweight. Circulation: 1997; 95 7 1837 1843 (Pubitemid 27164401)
18. Klaaborg KE, Egeblad H, Jakobsen CJ., et al. Transapical transcatheter treatment of a stenosed aortic valve bioprosthesis using the Edwards SAPIEN Transcatheter Heart Valve. Ann Thorac Surg: 2009; 87 6 1943 1946
19. Gualis J, Castaño M, Gómez-Plana J, Callejo F. Mitroflow bioprosthesis stent deformation: a rare cause of early prosthetic stenosis. Heart Surg Forum: 2009; 12 2 E121 E122
20. Matsuzaki K, Unno H, Konishi T, Shigeta O. Left coronary ostial obstruction after aortic valve replacement with a supra-annular aortic valve. Jpn J Thorac Cardiovasc Surg: 2006; 54 5 199 202 (Pubitemid 43973900)